1.Guzman, MG, et al. Dengue: a continuing global threat. Nature Reviews Microbiology 2010; 8: S7–16.
2.San Martin, JL, et al. The epidemiology of dengue in the americas over the last three decades: a worrisome reality. American Journal of Tropical Medicine and Hygiene 2010; 82: 128–135.
3.Teixeira, MG, et al. Dengue: twenty-five years since reemergence in Brazil. Cad Saude Publica 2009; 25: S7–18.
4.Swaminathan, S, Batra, G, Khanna, N. Dengue vaccines: state of the art. Expert Opinion on Therapeutic Patents 2010; 20: 819–835.
5.Kyle, JL, Harris, E. Global spread and persistence of dengue. Annual Review of Microbiology 2008; 62: 71–92.
6.Rico-Hesse, R. Dengue virus virulence and transmission determinants. Current Topics in Microbiology and Immunology 2010; 338: 45–55.
7.Halstead, SB. Dengue. Lancet 2007; 370: 1644–1652.
8.Kuno, G. Review of the factors modulating dengue transmission. Epidemiologic Reviews 1995; 17: 321–335.
9.Ferguson, NM, Donnelly, CA, Anderson, RM. Transmission dynamics and epidemiology of dengue: insights from age-stratified sero-prevalence surveys. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences 1999; 354: 757–768.
10.Simasathien, S, et al. Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children. American Journal of Tropical Medicine and Hygiene 2008; 78: 426–433.
11.Capeding, RZ, et al. Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines. Vaccine 2011; 29: 3863–3872.
12.Reiskind, MH, et al. Epidemiological and ecological characteristics of past dengue virus infection in Santa Clara, Peru. Tropical Medicine and International Health 2001; 6: 212–218.
13.Sangkawibha, N, et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. American Journal of Epidemiology 1984; 120: 653–669.
14.Sanchez-Burgos, GG, et al. Prevalence of neutralizing antibodies to dengue virus serotypes in university students from Tabasco, Mexico. Salud Publica de Mexico 2008; 50: 362–366.
15.Roehrig, JT, Hombach, J, Barrett, AD. Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses. Viral Immunology 2008; 21: 123–132.
17.Braga, C, et al. Seroprevalence and risk factors for dengue infection in socio-economically distinct areas of Recife, Brazil. Acta Tropica 2010; 113:234–240.
19.Cordeiro, MT, et al. Dengue and dengue hemorrhagic fever in the State of Pernambuco, 1995–2006. Revista da Sociedade Brasileira de Medicina Tropical 2007; 40: 605–611.
20.Montenegro, D, et al. Clinical and epidemiological aspects of the dengue epidemic in Recife, PE, 2002. Revista da Sociedade Brasileira de Medicina Tropical 2006; 39: 9–13.
21.Scheaffer, RL, Mendenhall, W, Ott, RL. Simple random sampling. In: Scheaffer, RL, ed. Elementary Survey Sampling. Boston: Duxbury, 1979, pp. 48–49.
22.Morens, DM, et al. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. Journal of Clinical Microbiology 1985; 22: 250–254.
23.Egger, JR, et al. Reconstructing historical changes in the force of infection of dengue fever in Singapore: implications for surveillance and control. Bulletin of the World Health Organization 2008; 86: 187–196.
24.Anderson, R, May, R. Infectious Diseases of Humans: Dynamics and Control, 1st edn.New York: Oxford University Press, 1991, pp. 63.
25.Nogueira, RM, de Araujo, JM, Schatzmayr, HG. Dengue viruses in Brazil, 1986–2006. Revista Panamericana de Salud Publica 2007; 22: 358–363.
26.Pessanha, JEM, et al. Dengue fever in three sanitary districts in the city of Belo Horizonte, Brazil: a population-based seroepidemiological survey, 2006 to 2007. Revista Panamericana de Salud Publica 2010; 27: 252–258.
27.Siqueira, JB, et al. Dengue and dengue hemorrhagic fever, Brazil, 1981–2002. Emerging Infectious Diseases 2005; 11: 48–53.
28.Chang, SF, et al. Retrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000. Journal of Microbiology, Immunology and Infection 2008; 41: 377–385.
29.Wilder-Smith, A, et al. Serological evidence for the co-circulation of multiple dengue virus serotypes in Singapore. Epidemiology and Infection 2005; 133: 667–671.
30.Gubler, DJ. Dengue and dengue hemorrhagic fever. Clinical Microbiology Reviews 1998; 11: 480–496.
31.Cavalcanti, LP, et al. Change in age pattern of persons with dengue, northeastern Brazil. Emerging Infectious Diseases 2011; 17: 132–134.
32.Endy, TP, et al. Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand. PLoS Neglected Tropical Diseases 2011; 5: e975.
33.Guzman, MG, et al. Epidemiologic studies on Dengue in Santiago de Cuba, 1997. American Journal of Epidemiology 2000; 152: 793–799.
34.Alencar Ximenes, RA, et al. Multilevel analysis of hepatitis A infection in children and adolescents: a household survey in the Northeast and Central-west regions of Brazil. International Journal of Epidemiology 2008; 37: 852–861.
35.Rodriguez-Barraquer, I, et al. From re-emergence to hyperendemicity: the natural history of the dengue epidemic in Brazil. PLoS Neglected Tropical Diseases 2011; 5: e935.